Pharma giants pressed by Senate Democrats over Trump pricing deals
Source: SeekingAlpha
2026-03-06 10:45:02 ET
More on Pfizer, Merck, etc.
- Pfizer: Obesity Hype And Vaccine Policy Shocks
- AbbVie: Stabilizes Near $233 While Testing Resistance
- Pfizer's Portfolio Renewal In Progress - High Yields For The Patient
- China approves Pfizer’s GLP-1 drug for weight management, intensifying market competition
- J&J wins FDA nod for multiple myeloma therapy
Read the full article on Seeking Alpha
For further details see:
Pharma giants pressed by Senate Democrats over Trump pricing deals
Gilead Sciences Inc.
NASDAQ: GILD
GILD Trading
2.03% G/L:
$148.52 Last:
1,201,455 Volume:
$147.73 Open:
GILD Latest News
March 03, 2026 09:00:00 am
Immunotherapy Delivers Across Tumor Types as Oncology Market Eyes $750 Billion
March 02, 2026 08:30:00 am
Gilead Foundation Awards $12 Million to Empower Community Health Workers and Expand HIV Prevention Initiatives Across 14 States and the District of Columbia
February 25, 2026 01:44:00 pm
Gilead's Single-Tablet Regimen of Bictegravir and Lenacapavir Maintained Virological Suppression in People With HIV Who Switched Antiretroviral Therapy
February 24, 2026 10:58:00 am
Oncology Market Set to Nearly Triple: Here Are Five Companies Leading the Charge
GILD Stock Data
$185,419,569,657
1,228,272,827
0.07%
1237
N/A
Pharmaceuticals
Healthcare
US
Foster City
